The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Plain Language Summary Development in Japan: Current State and Challenges
This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
Artificial Intelligence Is Democratizing Research and There’s More to Come
Today AI technologies are employed to both create and consume research. Scientists across the world...
Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence
The right AI–powered tools and techniques can make a significant difference in how research is...
Publication Planning Training for Regional Medical Affairs Team
How a global pharma company overcame challenges of integration with regional teams in terms of...
US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies
This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...